Answers are grounded in this paper and cite their sources.
Apilimod was well-tolerated but did not demonstrate efficacy over placebo in patients with active CD.
No takes yet. Share an insight, caveat, or question.
Sands et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: